Close
Enter your
text here

Blood clots

New Consensus Guidance Addresses Antithrombotic Management in Infants With Congenital Heart Disease
 New Consensus Guidance Addresses Antithrombotic Management in Infants With Congenital Heart Disease 1024 670 Lauren Dembeck
By: Lauren Dembeck

New AATS consensus recommendations aim to reduce variation in antithrombotic testing, treatment, and monitoring for neonates and infants undergoing cardiac interventions. Antithrombotic management around cardiac procedures can be particularly challenging in neonates and infants, whose hemostatic systems differ from those of older children and adults. Limited population-specific evidence has contributed to substantial variation in practice…

Increasing Use of Pharmacologic Clot Prevention Among Adolescents with Sickle Cell Disease
 Increasing Use of Pharmacologic Clot Prevention Among Adolescents with Sickle Cell Disease 1024 580 Mary Bates, PhD
By: Mary Bates, PhD

Growing interest in preventing thrombosis and approval of direct oral anticoagulants may be driving a shift to pharmacologic thromboprophylaxis. In a new study, researchers from Nationwide Children’s Hospital assessed the use of thromboprophylaxis in adolescent patients with sickle cell disease over the last decade. Sickle cell disease (SCD) increases the risk of venous thromboembolism (VTE).…